** Jefferies anticipates medium-term growth in healthcare service sector, propelled by increasing bulk billing and potential new incentives from the govt
** In FY25E, Jefferies continues to forecast market revenue growth of 10% in diagnostic imaging, 6% in pathology and 2.5% in assisted reproductive services on YOY basis
** Notes that despite recent decline in General Practitioner bulk-billing rates leading to lower clinical lab volumes, there's evidence of this trend reversing
** Maintains its forecasts for Healius HLS.AX, Integral Diagnostics IDX.AX, Monash IVF MVF.AX, and Sonic Healthcare SHL.AX
** Healthcare .AXHJ index down 8.1%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.